Pyridoxine-Responsive Seizures in Infantile Hypophosphatasia and a Novel Homozygous Mutation in ALPL Gene

Hypophosphatasia is a rare inherited disorder of bone and mineral metabolism caused by a number of loss-of-function mutations in the ALPL gene. It is characterized by defective bone and tooth mineralisation associated with low serum and bone alkaline phosphatase activity. The clinical presentation of this disease is extremely variable. For this reason, the diagnosis can be difficult and is often missed out or delayed. Hypophosphatasia is classified into subtypes based on the age of onset and clinical features. The clinical severity is associated with the age at diagnosis and the lack of tissue-nonspecific alkaline phosphatase activity; the severe forms of hypophosphatasia are primarily perinatal and infantile forms. Severe forms may present with many neurological problems such as seizures, hypotonia, irritability. Herein, we report the case of an infantile hypophosphatasia patient who presented with pyridoxineresponsive seizures and a novel homozygous mutation in the ALPL gene was detected. There is a limited number of hypophosphatasia patients with pyridoxine-responsive seizures in the literature, so early diagnosis of infantile hypophosphatasia in the clinically compatible patients allows more effective postnatal care/management and genetic counseling for further pregnancies.

Kaynakça

Rathbun JC. Hypophosphatasia: a new developmental anomaly. Am J Dis Child 1948;75:822-834.

Whyte MP. Hypophosphatasia. In: Thakker RV, Whyte MP, Eisman J, Igarashi T (eds). Genetics of bone biology and skeletal disease. London, Academic Press, 2012;337-360.

Taillandier A, Sallinen SL, Brun-Heath I, De Mazancourt P, Serre JL, Mornet E. Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene. J Clin Endocrinol Metab 2005;90:2436- 2439. Epub 2005 Jan 25

Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 2009;10:51.

Spentchian M, Merrien Y, Herasse M, Dobbie Z, Gläser D, Holder SE, Ivarsson SA, Kostiner D, Mansour S, Norman A, Roth J, Stipoljev F, Taillemite JL, van der Smagt JJ, Serre JL, Simon-Bouy B, Taillandier A, Mornet E. Severe hypophosphatasia: characterization of fifteen novel mutations in the ALPL gene. Hum Mutat 2003;22:105-106.

Sergi C, Mornet E, Troeger J, Voigtlaender T. Perinatal hypophosphatasia: radiology, pathology and molecular biology studies in a family harboring a splicing mutation (648+1A) and a novel missense mutation (N400S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene. Am J Med Genet 2001;103:235-240.

Whyte MP. Hypophosphatasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 2001:5313-5329.

Hollis A, Arundel P, High A, Balmer R. Current concepts in hypophosphatasia: case report and literature review. Int J Paediatr Dent 2013;23:153-159. Epub 2012 Jun 4

Whyte MP. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010;1192:190-200.

Bianchi ML. Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int 2015;26:2743-2757. Epub 2015 Aug 6

Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Bürgi S, Sergi C, Ryan L, Ericson KL, Whyte MP, Högler W. Pyridoxine- responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 2007;40:1655-1661. Epub 2007 Feb 14

Nunes ML, Mugnol F, Bica I, Fiori RM. Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn. J Child Neurol 2002;17:222-224.

Baxter P. Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim Biophys Acta 2003;1647:36- 41.

Litmanovitz I, Reish O, Dolfin T, Arnon S, Regev R, Grinshpan G, Yamazaki M, Ozono K. Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. J Inherit Metab Dis 2002;25:35-40.

Yamamoto H, Sasamoto Y, Miyamoto Y, Murakami H, Kamiyama N. A successful treatment with pyridoxal phosphate for West syndrome in hypophosphatasia. Pediatr Neurol 2004;30:216-218.

Demirbilek H, Alanay Y, Alikaşifoğlu A, Topçu M, Mornet E, Gönç N, Özön A, Kandemir N. Hypophosphatasia presenting with pyridoxine-responsive seizures, hypercalcemia, and pseudotumor cerebri: case report. J Clin Res Pediatr Endocrinol 2012;4:34-38.

Wei KW, Xuan K, Liu YL, Fang J, Ji K, Wang X, Jin Y, Watanabe S, Watanabe K, Ojihara T. Clinical, pathological and genetic evaluations of Chinese patients with autosomal- dominant hypophosphatasia. Arch Oral Biol 2010;55:1017- 1023. Epub 2010 Sep 9

Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML, Hamdan MA, Bishop N, Lutz RE, McGinn M, Craig S, Moore JN, Taylor JW, Cleveland RH, Cranley WR, Lim R,Thacher TD, Mayhew JE, Downs M, Millán JL, Skrinar AM, Crine P, Landy H. Enzyme-replacement therapy in life- threatening hypophosphatasia. N Engl J Med 2012;366:904- 913.

Kaynak Göster

  • ISSN: 1308-5727
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2008

2.3b 2.3b

Sayıdaki Diğer Makaleler

Are Vitamin D Drops Containing 400 IU Daily Adequate for Preventing Vitamin D Deficiency?

Hüseyin ANIL KORKMAZ

Pyridoxine-Responsive Seizures in Infantile Hypophosphatasia and a Novel Homozygous Mutation in ALPL Gene

Banu GÜZEL NUR, Gamze ÇELMELİ, AYŞE ESRA MANGUOĞLU AYDEMİR, ERDOĞAN SOYUÇEN, İffet BİRCAN, ERCAN MIHÇI

The Role of Active Video-Accompanied Exercises in Improvement of the Obese State in Children: A Prospective Study from Turkey

FATMA DUMAN, MEHMET HANİFİ KOKAÇYA, ESRA DOĞRU HÜZMELİ, NİHAN KATAYIFÇI, Özden CANBAY, Fatma AMAN

Attitudes of Pediatricians Regarding Prevention and Treatment of Vitamin D Deficiency

Gülcan SEYMEN KARABULUT, ŞÜKRÜ HATUN, AYSUN BİDECİ, Enver HASANOĞLU

The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study

ZEYNEP ŞIKLAR, Mikayir GENENS, ŞÜKRAN POYRAZOĞLU, FİRDEVS BAŞ, FATMA FEYZA DARENDELİLER, RÜVEYDE BUNDAK, ZEHRA AYCAN, ŞENAY SAVAŞ ERDEVE, SEMRA ÇETİNKAYA, AYLA GÜVEN, SAYGIN ABALI, Zeynep ATAY, Serap TURAN, CENGİZ KARA, Gülay Can YILMAZ, Nesibe AKYÜREK, AYHAN ABACI, Gamze ÇELMELİ, Erkan SARI, Semih BOLU, Hüseyin ANIL K

Crouzonodermoskeletal Syndrome with Hypoplasia of Corpus Callosum and Inferior Vermis

FATİH GÜRBÜZ, Serdar CEYLANER, Ali Kemal TOPALOĞLU, BİLGİN YÜKSEL

Endocrine Dysfunctions in Patients with Inherited Metabolic Diseases

ŞAHİN ERDÖL, HALİL SAĞLAM

The Relationship between Maternal Gestational Impaired Glucose Tolerance and Risk of Large-for-Gestational-Age Infant: A MetaAnalysis of 14 Studies

Hai-Qing WANG, Han-Lin LAİ, Yi LI, Qi-Fei LİU, Shuang Hu, Li Lİ

Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy

Dinesh GİRİ, Victoria PRİCE, Zoe YUNG, Mohammed DİDİ, Senthil SENNİAPPAN

Pseudotumour Cerebri Presentation in a Child Under the Gonadotropin-Releasing Hormone Agonist Treatment

Ülkü GÜL, Ayşe KAÇAR BAYRAM, MUSTAFA KENDİRCİ, Nihal HATİPOĞLU, Deniz OKDEMİR, Hakan GÜMÜŞ, Selim KURTOĞLU